One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease

Author： Brazinsky S.A.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.23, Iss.3, 2003-01, pp. : 181-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of Ipratropium Bromide/Fenoterol Hydrobromide (Berodual ® ) Delivered Via Respimat ® Soft Mist™ Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Disease

By Frank Kässner  

Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. : 1671-1682

Adis International

Access to resources Recommend Favorite

Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease

By Gordon Joshiah   Panos Ralph J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 381-392

Informa Healthcare

Access to resources Recommend Favorite

Formoterol Monotherapy Compared with Combined Ipratropium Bromide plus Fenoterol in the Treatment of Chronic Obstructive Pulmonary Disease

By Konermann M.  

Clinical Drug Investigation, Vol. 21, Iss. 4, 2001-04 ,pp. : 235-242

Adis International

Access to resources Recommend Favorite

Efficacy of Beclomethasone Dipropionate HFA 200 μg Once Daily in Chronic Obstructive Pulmonary Disease and Bronchial Asthma

By Tatsis G   Kotsifas K   Filaditaki V   Makrantoni G   Boulia S  

The Journal of International Medical Research, Vol. 35, Iss. 3, 2007-05 ,pp. : 361-373

Field House Publishing

Access to resources Recommend Favorite

Tiotropium Bromide Inhalation Powder: A Review of its Use in the Management of Chronic Obstructive Pulmonary Disease

By Keating Gillian M.  

Drugs, Vol. 72, Iss. 2, 2012-01 ,pp. : 273-300

Adis International

Access to resources Recommend Favorite